A Reply to Holman’s Criticisms of EBM+

November 28, 2019 Jon Williamson

In two recent papers [(2017) Philosophers on drugs, Synthese, pp. 1-28, and (2018) In defense of meta-analysis, Synthese, pp. 1-23], Bennett Holman has criticized EBM+. I have replied to these criticisms, in a paper, which discusses issues of industrial funding and meta-analysis in relation to EBM+. For a downloadable pdf of this paper click here: Gillies (2019) Holman’s Criticisms of EBM+

Donald Gillies
University College London